nam/aidsmap, Published: 22 February 2017 A study of PrEP users presented last week showed that PrEP users had very high rates of STI diagnosis – in the order of 20 times higher than among HIV-negative gay men in the general population. The evidence that STIs increased further while people were on PrEP was, however, a lot more ambiguous. The problem in proving that PrEP has any causal relationship...
Gay News Network, Wednesday 18 January 2017 The Victorian AIDS Council has announced it will give an additional $100,000 to the PrEPX trial to fund access to pre-exposure prophylaxis for HIV (PrEP) for 600 Victorians at risk. VAC’s announcement comes months after PrEPX reached capacity for men living in metropolitan Melbourne. The VAC said there is already a substantial waiting list for those...
Jay Weatherill MP, Nat Cook MP, Wednesday, November 29, 2016 South Australians at high risk of contracting HIV will have access to the latest preventative technology study, as part of a State Government commitment announced today. Pre-exposure prophylaxis or PrEP is the latest prevention therapy in the fight against HIV. Under a PrEP access trial, eligible South Australians who don’t have HIV and...
ABC News, 24/11/16 The Greens want South Australia to be part of a trial for a pill which can reduce the risk of HIV infection and is already being widely used overseas. The drug called PrEP — short for pre exposure prophylaxis — is made up of antiretroviral drugs taken by HIV-negative people to prevent HIV infection, according to the ACON website, which is primarily funded by the NSW Ministry of...
Journal of the International AIDS Society 2016, 19:21165 Abstract: Introduction: An estimated 1.2 million Americans have indications for using antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV acquisition. For many of these at-risk individuals, the best opportunity to learn about and receive PrEP will be during routine visits to their generalist primary care clinicians. However, few...
BETA Blog, September 8, 2016 How many doses of Truvada-based PrEP (pre-exposure prophylaxis) are needed to provide adequate protection against HIV? Might it be possible to take PrEP only before and after sex—instead of every day? A recent article published in The Lancet HIV provides insight into this very question. Read more here Access Lancet HIV abstract here (for full text please see your...